Drug treatment of nonviral sexually transmitted diseases: Specific issues in adolescents

Paediatric Drugs

Volumn 3, Issue 7, 2001, Pages 481-494

  Lehmann, Corinne E ^a   Biro, Frank M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFIXIME; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; FLUCONAZOLE; GENTAMICIN; METRONIDAZOLE; OFLOXACIN; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE;

ADOLESCENCE; ADOLESCENT; ANTIBIOTIC SENSITIVITY; CHLAMYDIASIS; COST CONTROL; DISEASE TRANSMISSION; GONORRHEA; GRANULOMA INGUINALE; HUMAN; INFECTION RISK; LYMPHOGRANULOMA VENEREUM; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEXUAL ABUSE; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; ULCUS MOLLE; URETHRITIS; UTERINE CERVICITIS; VAGINITIS;

ADOLESCENT; HUMANS; SEXUALLY TRANSMITTED DISEASES;

EID: 0034896529     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200103070-00001     Document Type: Review

References (58)

1. Sexually transmitted diseases in adolescents
2. Recognizing and treating STDs in adolescent girls
3. Sexually transmitted diseases among adolescents in developed countries
4. Adolescents and sexually transmitted diseases
5. Sexually transmitted diseases: Testing and treating
6. Cervical Chlamydia trachomatis infection in university women: Relationship to history, contraception, ectopy, and cervicitis
7. Adolescent's perceptions of factors affecting their decisions to seek health care
8. The pediatrician and the sexually active adolescent - A primer for sexually transmitted diseases
9. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis
10. 1998 Guidelines for treatment of sexually transmitted diseases
11. Clinical effectiveness guidelines
12. New treatments for chlamydia trachomatis genital infection
13. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents
14. Compliance with doxycycline therapy in sexually transmitted diseases clinics
15. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes
16. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women
17. Adequate macrolide treatment schedules for uterine cervicitis caused by chlamydia trachomatis
18. Adequate levofloxacin treatment schedules for uterine cervicitis caused by chlamydia trachomatis
19. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure
20. Drugs of choice for the treatment of uncomplicated gonococcal infections
21. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men
22. Concurrent gonococcal and chlamydial infection: How best to treat
23. The impact of antimicrobial resistance on the treatment of sexually transmitted diseases
24. Fluoroquinolone-resistance in Neisseria gonorrhea, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhea, Missouri, 1999
25. Achilles tendonitis associated with fluoroquinolones
26. Ciprofloxacin safety in a pediatric population
27. Ciprofloxacin in children: Is arthropathy a limitation?
28. Treating uncomplicated Neisseria gonorrhoeae infections: Is the anatomic site of infection important?
29. Practical recommendations for the drug treatment of bacterial infections of the male genital tract including urethritis, epididymitis and prostatitis
30. Diagnosing pelvic inflammatory disease: A comprehensive analysis and considerations for developing a new model
31. Pelvic inflammatory disease: Metaanalysis of antimicrobial regimen efficacy
32. Anaerobes in pelvic inflammatory disease: Implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases
33. Adolescent girls and pelvic inflammatory disease: Experience and practices of emergency department pediatricians
34. Medically sound, cost-effective treatment for pelvic inflammatory disease and tubo-ovarian abscess
35. Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wet-mount microscopy
36. Use of spun urine to enhance detection of Trichomonas vaginalis in adolescent women
37. Metronidazole for vaginal trichomoniasis
38. Treatment of vaginal trichomoniasis
39. Trichomonal vaginitis treated with one dose of metronidazole
40. Interventions for treating trichomoniasis in women
41. A double-blind study of the value of treatment with a single dose tinidazole of partners to females with trichomoniasis
42. Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy
43. Oral metronidazole vs. metrogel vaginal for treating bacterial vaginosis: Cost-effectiveness evaluation
44. Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vagthosis
45. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: A randomized trial
46. Treatment options for vulvo-vaginal candidiasis, 1993
47. Syphilis among adolescents: The hidden epidemic
48. Treatment of syphilis, 1998: Nonpregnant adults
49. Pilot study of azithromycin for treatment of primary and secondary syphilis
50. Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis
51. Treatment of early syphilis with azithromycin